Search

everythinglearnresearchcommunity

for

Search:↓

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

General surgeons in India need to manage peripheral arterial disease due to a shortage of vascular surgeons.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Hair cortisol can be used to measure long-term stress exposure.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Systemic sclerosis skin shows varied gene patterns, suggesting potential for personalized treatment.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Tph cells are linked to the severity of systemic lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

COVID-19 vaccination may trigger lupus in some people.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Prednisone may cause multiple skin nodules in lupus patients.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Hair loss in lupus patients indicates higher disease activity.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

PUVA treatment may have triggered lupus in a woman with psoriasis.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.